Virginia Cancer Specialists - Fairfax Office

Fairfax, Virginia 22031

1 studies enrolling now · 5 studies all time

What they study most

Acute Myeloid Leukemia, Adjuvant, Advanced Malignancies, Carcinoma, Carcinoma, Non-Small-Cell Lung, EGFR, Early Stage Lung Cancer, Exon 20, Extra-Pancreatic Neuroendocrine Tumor (epNET), Lung Cancer, NSCLC, Stage IB-IIIA, Non-small Cell Lung Cancer

Studies at this site

• Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors — Recruiting now
• A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection — Running, not enrolling
• A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer — Running, not enrolling
• Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML) — Completed
• ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants — Completed